|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2007 The American Thoracic Society doi: 10.1513/pats.200605-129JG Strategies for Identifying Modifier Genes in Cystic FibrosisDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland Correspondence and requests for reprints should be addressed to Michael P. Boyle, M.D., The Johns Hopkins University School of Medicine, 1830 East Monument Street, 5th floor, Baltimore, MD 21205. E-mail: mboyle{at}jhmi.edu ABSTRACT Even in patients with cystic fibrosis (CF) with identical CFTR genotypes, there is a wide range in the severity of lung disease, with some individuals facing death or lung transplantation early in life and others demonstrating mild lung disease well into adulthood. Although numerous environmental factors have been identified that influence CF pulmonary phenotype, there is now growing evidence that polymorphic variants in genes besides CFTR play an important role in determining severity of CF lung disease. This article reviews the most recent findings regarding genetic modifiers in CF and also discusses in detail the strategies currently being used to identify novel modifiers of CF pulmonary phenotype. These include single- and multicenter studies, twin and sib studies, microarray approaches, and whole genome association studies.
Key Words: cystic fibrosis genotype modifier phenotype transforming growth factor ß This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||